Records containing: Pulmonary Arterial Hypertension
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-13A Phase 3, Prospective, Multicenter, Double-blind, Double-dummy, Randomized, Active-controlled, Parallel-group, Group-sequential, Adaptive, Event-driven Study to Compare Efficacy, Safety, and Tolerability of Macitentan 75 mg Versus Macitentan 10 mg in Patients With Pulmonary Arterial Hypertension, Followed by an Open-label Treatment Period With Macitentan 75 mg
-
CLINICAL_TRIALS study record update · 2026-04-09A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Inhalation of Seralutinib for the Treatment of Pulmonary Arterial Hypertension (PAH)
-
CLINICAL_TRIALS study record update · 2026-04-09An Open-label Extension Study Evaluating the Long-term Safety and Efficacy of Oral Inhalation of GB002 for the Treatment of WHO Group 1 Pulmonary Arterial Hypertension (PAH)
-
CLINICAL_TRIALS study record update · 2026-04-08A Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of Oxacom® in Different Dosages in Patients With Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2026-04-06A Phase 2a, Dose Escalation Study to Evaluate the Effect of RT234 on Cardiopulmonary Hemodynamics in Subjects With Pulmonary Arterial Hypertension
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-06Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs
-
CLINICAL_TRIALS study record update · 2026-04-03Assessment of Right Ventricular Function by Cardiac Magnetic Resonance Imaging in Patients With Pulmonary Arterial Hypertension (IRMA)
-
CLINICAL_TRIALS study record update · 2026-04-02ADAPT - A Patient Registry of the Real-world Use of Orenitram®
-
CLINICAL_TRIALS study record update · 2026-04-01A Phase 3, 2-Part, Open-Label Study to Evaluate the Safety and Tolerability of Liposomal Treprostinil Inhalation Suspension (L606) in Subjects With Pulmonary Arterial Hypertension or Pulmonary Hypertension Associated With Interstitial Lung Disease
-
CLINICAL_TRIALS study record update · 2026-03-31RELIEVE-PAH TRIAL: REducing Right ventricuLar faIlure With thE V-waVe Shunt in Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2026-03-30A Phase 2b, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2026-03-27Auto-immunity and Prognosis of Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2026-03-27MhOVE-PPH Study: Mobile Health Intervention to Improve Exercise in Pediatric PH
-
CLINICAL_TRIALS study record update · 2026-03-19A Phase 3, Randomized, Double-Blind, Placebo-controlled, Multicenter, Parallel-group Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2026-03-19A Study on the Efficacy and Safety of Empagliflozin in the Treatment of Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2026-03-09Safety and Impact of Low Resistance Exercise Training on Quality of Life in Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2026-03-04A Phase 2, Multicentre, Open-Label Trial to Evaluate APL-9796 in Adult Participants With Pulmonary Hypertension (ViTAL-PH)
-
CLINICAL_TRIALS study record update · 2026-02-27Treprostinil Palmitil Inhalation Powder (TPIP) in Patients With Pulmonary Arterial Hypertension or Pulmonary Hypertension Associated With Interstitial Lung Disease
-
CLINICAL_TRIALS study record update · 2026-02-27A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Finding Trial to Evaluate the Efficacy and Safety of Orally Administered NS-863 in Participants With Pulmonary Arterial Hypertension (PAH)
-
CLINICAL_TRIALS study record update · 2026-02-24Defining a Noninvasive Signature for Pulmonary Vascular Remodeling in Group 3 PH
-
CLINICAL_TRIALS study record update · 2026-02-24129Xenon MR Imaging and Spectroscopy Response to Sotatercept in Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2026-02-24129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH)
-
CLINICAL_TRIALS study record update · 2026-02-20A Phase 3 Open-label Extension (OLE) Study to Evaluate the Long-term Safety and Efficacy of Ralinepag in Subjects With World Health Organization (WHO) Group 1 Pulmonary Arterial Hypertension (PAH)
-
CLINICAL_TRIALS study record update · 2026-02-18Clinical Trial of 2-HOBA in Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2026-02-09An Open-label Extension Study Evaluating the Long-term Safety and Efficacy of Seralutinib Orally Inhaled for the Treatment of Pulmonary Arterial Hypertension (PAH)